nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—TCN1—gall bladder—bile duct cancer	0.0636	0.132	CbGeAlD
Hydroxocobalamin—MUT—gall bladder—bile duct cancer	0.045	0.0935	CbGeAlD
Hydroxocobalamin—MMACHC—liver—bile duct cancer	0.0299	0.0622	CbGeAlD
Hydroxocobalamin—TCN1—pancreas—bile duct cancer	0.0293	0.061	CbGeAlD
Hydroxocobalamin—CASP9—pancreas—bile duct cancer	0.027	0.0562	CbGeAlD
Hydroxocobalamin—AMN—liver—bile duct cancer	0.0246	0.0512	CbGeAlD
Hydroxocobalamin—MUT—pancreas—bile duct cancer	0.0207	0.0431	CbGeAlD
Hydroxocobalamin—MMAA—liver—bile duct cancer	0.0196	0.0408	CbGeAlD
Hydroxocobalamin—AMN—lymph node—bile duct cancer	0.0189	0.0393	CbGeAlD
Hydroxocobalamin—MMAB—liver—bile duct cancer	0.0184	0.0382	CbGeAlD
Hydroxocobalamin—CASP9—liver—bile duct cancer	0.0172	0.0357	CbGeAlD
Hydroxocobalamin—TCN2—liver—bile duct cancer	0.0168	0.0349	CbGeAlD
Hydroxocobalamin—MTR—pancreas—bile duct cancer	0.0162	0.0338	CbGeAlD
Hydroxocobalamin—CUBN—lymph node—bile duct cancer	0.0159	0.0331	CbGeAlD
Hydroxocobalamin—MMAA—lymph node—bile duct cancer	0.015	0.0313	CbGeAlD
Hydroxocobalamin—MMAB—lymph node—bile duct cancer	0.0141	0.0293	CbGeAlD
Hydroxocobalamin—MUT—liver—bile duct cancer	0.0132	0.0274	CbGeAlD
Hydroxocobalamin—CASP9—lymph node—bile duct cancer	0.0132	0.0274	CbGeAlD
Hydroxocobalamin—TCN2—lymph node—bile duct cancer	0.0129	0.0267	CbGeAlD
Hydroxocobalamin—MTRR—liver—bile duct cancer	0.0118	0.0246	CbGeAlD
Hydroxocobalamin—MTR—liver—bile duct cancer	0.0103	0.0215	CbGeAlD
Hydroxocobalamin—MUT—lymph node—bile duct cancer	0.0101	0.021	CbGeAlD
Hydroxocobalamin—MTRR—lymph node—bile duct cancer	0.00908	0.0189	CbGeAlD
Hydroxocobalamin—MTR—lymph node—bile duct cancer	0.00792	0.0165	CbGeAlD
Hydroxocobalamin—CASP9—Signaling by ERBB2—NRAS—bile duct cancer	0.000934	0.0018	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—NRAS—bile duct cancer	0.000929	0.00179	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—GNAS—bile duct cancer	0.000926	0.00178	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—SMAD4—bile duct cancer	0.000922	0.00178	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—NRAS—bile duct cancer	0.000916	0.00176	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—EGFR—bile duct cancer	0.000914	0.00176	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—NRAS—bile duct cancer	0.000911	0.00175	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—EGFR—bile duct cancer	0.000904	0.00174	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—KRAS—bile duct cancer	0.000902	0.00174	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—EGFR—bile duct cancer	0.0009	0.00173	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—TGFBR2—bile duct cancer	0.000899	0.00173	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000876	0.00169	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—NRAS—bile duct cancer	0.000874	0.00168	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—NRAS—bile duct cancer	0.000874	0.00168	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—NRAS—bile duct cancer	0.000874	0.00168	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—NOS2—bile duct cancer	0.000868	0.00167	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—NOS2—bile duct cancer	0.000868	0.00167	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—NRAS—bile duct cancer	0.000866	0.00167	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—KRAS—bile duct cancer	0.000863	0.00166	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—EGFR—bile duct cancer	0.000859	0.00165	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—NRAS—bile duct cancer	0.000859	0.00165	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—EGFR—bile duct cancer	0.000855	0.00165	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—NRAS—bile duct cancer	0.000855	0.00165	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—KRAS—bile duct cancer	0.000854	0.00165	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IDH1—bile duct cancer	0.000853	0.00164	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—SMAD4—bile duct cancer	0.000851	0.00164	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—EGFR—bile duct cancer	0.000851	0.00164	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—KRAS—bile duct cancer	0.00085	0.00164	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—TGFB1—bile duct cancer	0.000847	0.00163	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—EGFR—bile duct cancer	0.000847	0.00163	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—EGFR—bile duct cancer	0.000834	0.00161	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—EGFR—bile duct cancer	0.00083	0.0016	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—GNAS—bile duct cancer	0.000825	0.00159	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—GNAS—bile duct cancer	0.000825	0.00159	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—KRAS—bile duct cancer	0.000812	0.00156	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—NRAS—bile duct cancer	0.000809	0.00156	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—KRAS—bile duct cancer	0.000808	0.00156	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—NOS2—bile duct cancer	0.000807	0.00155	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—KRAS—bile duct cancer	0.000804	0.00155	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—KRAS—bile duct cancer	0.0008	0.00154	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—EGFR—bile duct cancer	0.000796	0.00153	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—EGFR—bile duct cancer	0.000796	0.00153	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—EGFR—bile duct cancer	0.000796	0.00153	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—EGFR—bile duct cancer	0.000789	0.00152	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—KRAS—bile duct cancer	0.000788	0.00152	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—GNAS—bile duct cancer	0.000787	0.00152	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—KRAS—bile duct cancer	0.000784	0.00151	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—ERBB2—bile duct cancer	0.000783	0.00151	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—EGFR—bile duct cancer	0.000782	0.00151	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—EGFR—bile duct cancer	0.000779	0.0015	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—NRAS—bile duct cancer	0.000774	0.00149	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—SLC5A5—bile duct cancer	0.000768	0.00148	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—HRAS—bile duct cancer	0.000767	0.00148	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.000764	0.00147	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—TP53—bile duct cancer	0.000759	0.00146	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—KRAS—bile duct cancer	0.000752	0.00145	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—KRAS—bile duct cancer	0.000752	0.00145	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—KRAS—bile duct cancer	0.000752	0.00145	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.000749	0.00144	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—KRAS—bile duct cancer	0.000746	0.00144	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TP53—bile duct cancer	0.000744	0.00143	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—KRAS—bile duct cancer	0.000739	0.00142	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—TGFBR2—bile duct cancer	0.000738	0.00142	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—EGFR—bile duct cancer	0.000737	0.00142	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—KRAS—bile duct cancer	0.000736	0.00142	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—IL6—bile duct cancer	0.000734	0.00141	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—HRAS—bile duct cancer	0.000734	0.00141	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—GNAS—bile duct cancer	0.000726	0.0014	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—HRAS—bile duct cancer	0.000722	0.00139	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—NOS2—bile duct cancer	0.000719	0.00139	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—NOS2—bile duct cancer	0.000719	0.00139	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—ERBB2—bile duct cancer	0.000714	0.00137	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.000708	0.00136	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—EGFR—bile duct cancer	0.000705	0.00136	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—IL6—bile duct cancer	0.000702	0.00135	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—SMAD4—bile duct cancer	0.000699	0.00135	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—PTGS2—bile duct cancer	0.000698	0.00134	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—TP53—bile duct cancer	0.000697	0.00134	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—KRAS—bile duct cancer	0.000696	0.00134	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RNF43—bile duct cancer	0.000694	0.00134	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—IL6—bile duct cancer	0.000691	0.00133	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—HRAS—bile duct cancer	0.00069	0.00133	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—HRAS—bile duct cancer	0.000686	0.00132	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—NOS2—bile duct cancer	0.000686	0.00132	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—HRAS—bile duct cancer	0.000683	0.00132	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—HRAS—bile duct cancer	0.00068	0.00131	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—HRAS—bile duct cancer	0.00067	0.00129	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—KRAS—bile duct cancer	0.000666	0.00128	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—IL6—bile duct cancer	0.00066	0.00127	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—IL6—bile duct cancer	0.000657	0.00127	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—IL6—bile duct cancer	0.000654	0.00126	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—ERBB2—bile duct cancer	0.000653	0.00126	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—ERBB2—bile duct cancer	0.000653	0.00126	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—IL6—bile duct cancer	0.000651	0.00125	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—HRAS—bile duct cancer	0.000639	0.00123	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—HRAS—bile duct cancer	0.000639	0.00123	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—HRAS—bile duct cancer	0.000639	0.00123	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PTGS2—bile duct cancer	0.000638	0.00123	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—PTGS2—bile duct cancer	0.000638	0.00123	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—HRAS—bile duct cancer	0.000634	0.00122	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NOS2—bile duct cancer	0.000633	0.00122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.000629	0.00121	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—HRAS—bile duct cancer	0.000628	0.00121	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—SLC5A5—bile duct cancer	0.000626	0.0012	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—HRAS—bile duct cancer	0.000625	0.0012	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—IL6—bile duct cancer	0.000612	0.00118	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—IL6—bile duct cancer	0.000612	0.00118	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—IL6—bile duct cancer	0.000612	0.00118	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—ERBB2—bile duct cancer	0.000607	0.00117	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—IL6—bile duct cancer	0.000607	0.00117	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TGFBR2—bile duct cancer	0.000602	0.00116	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—IL6—bile duct cancer	0.000601	0.00116	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—IL6—bile duct cancer	0.000599	0.00115	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—GNAS—bile duct cancer	0.000596	0.00115	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—NRAS—bile duct cancer	0.000595	0.00115	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PTGS2—bile duct cancer	0.000594	0.00114	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—HRAS—bile duct cancer	0.000592	0.00114	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PTGS2—bile duct cancer	0.000585	0.00113	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SMAD4—bile duct cancer	0.00057	0.0011	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—HRAS—bile duct cancer	0.000566	0.00109	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—NRAS—bile duct cancer	0.000543	0.00105	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—EGFR—bile duct cancer	0.000543	0.00104	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—IL6—bile duct cancer	0.000542	0.00104	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—ERBB2—bile duct cancer	0.000541	0.00104	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—ERBB2—bile duct cancer	0.000541	0.00104	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PTGS2—bile duct cancer	0.000535	0.00103	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PTGS2—bile duct cancer	0.000535	0.00103	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PTGS2—bile duct cancer	0.000529	0.00102	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PTGS2—bile duct cancer	0.000529	0.00102	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NOS2—bile duct cancer	0.00052	0.001	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—ERBB2—bile duct cancer	0.000516	0.000994	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—KRAS—bile duct cancer	0.000513	0.000987	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PTGS2—bile duct cancer	0.000505	0.000972	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—TGFB1—bile duct cancer	0.000505	0.000972	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTGS2—bile duct cancer	0.000497	0.000957	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—NRAS—bile duct cancer	0.000497	0.000957	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—NRAS—bile duct cancer	0.000497	0.000957	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—EGFR—bile duct cancer	0.000495	0.000953	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GNAS—bile duct cancer	0.000486	0.000936	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—ERBB2—bile duct cancer	0.000476	0.000917	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—KRAS—bile duct cancer	0.000467	0.0009	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTGS2—bile duct cancer	0.000466	0.000897	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—NRAS—bile duct cancer	0.000462	0.000889	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—TGFB1—bile duct cancer	0.000462	0.000889	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—TGFB1—bile duct cancer	0.000462	0.000889	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TGFBR2—bile duct cancer	0.000453	0.000872	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—EGFR—bile duct cancer	0.000453	0.000871	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—EGFR—bile duct cancer	0.000453	0.000871	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HGF—bile duct cancer	0.000451	0.000868	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—ERBB2—bile duct cancer	0.000446	0.00086	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTGS2—bile duct cancer	0.000443	0.000853	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTGS2—bile duct cancer	0.000443	0.000853	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—HRAS—bile duct cancer	0.000436	0.000839	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—TGFB1—bile duct cancer	0.000429	0.000826	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SMAD4—bile duct cancer	0.000429	0.000826	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—ERBB2—bile duct cancer	0.000429	0.000825	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—KRAS—bile duct cancer	0.000428	0.000823	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—KRAS—bile duct cancer	0.000428	0.000823	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NOS2—bile duct cancer	0.000424	0.000816	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTGS2—bile duct cancer	0.000423	0.000814	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—EGFR—bile duct cancer	0.000421	0.00081	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—IL6—bile duct cancer	0.000417	0.000803	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—NRAS—bile duct cancer	0.000412	0.000793	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—NRAS—bile duct cancer	0.000412	0.000793	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—KRAS—bile duct cancer	0.000397	0.000765	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—HRAS—bile duct cancer	0.000397	0.000765	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—NRAS—bile duct cancer	0.000393	0.000756	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—ERBB2—bile duct cancer	0.000391	0.000753	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTGS2—bile duct cancer	0.00039	0.000751	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—TGFB1—bile duct cancer	0.000382	0.000736	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—TGFB1—bile duct cancer	0.000382	0.000736	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTGS2—bile duct cancer	0.000382	0.000736	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—IL6—bile duct cancer	0.00038	0.000732	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—EGFR—bile duct cancer	0.000375	0.000722	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—EGFR—bile duct cancer	0.000375	0.000722	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—TGFB1—bile duct cancer	0.000365	0.000703	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—HRAS—bile duct cancer	0.000363	0.0007	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—HRAS—bile duct cancer	0.000363	0.0007	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NRAS—bile duct cancer	0.000362	0.000698	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—EGFR—bile duct cancer	0.000358	0.000689	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—KRAS—bile duct cancer	0.000354	0.000682	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KRAS—bile duct cancer	0.000354	0.000682	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—IL6—bile duct cancer	0.000348	0.00067	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—IL6—bile duct cancer	0.000348	0.00067	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—NRAS—bile duct cancer	0.00034	0.000654	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KRAS—bile duct cancer	0.000338	0.000651	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—HRAS—bile duct cancer	0.000338	0.000651	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—TGFB1—bile duct cancer	0.000337	0.000648	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—EGFR—bile duct cancer	0.00033	0.000636	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—NRAS—bile duct cancer	0.000326	0.000628	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—IL6—bile duct cancer	0.000323	0.000623	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTGS2—bile duct cancer	0.00032	0.000617	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOS2—bile duct cancer	0.000319	0.000615	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—ERBB2—bile duct cancer	0.000319	0.000614	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TGFBR2—bile duct cancer	0.000317	0.000611	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KRAS—bile duct cancer	0.000312	0.000601	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTGS2—bile duct cancer	0.000312	0.0006	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—EGFR—bile duct cancer	0.000309	0.000596	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GNAS—bile duct cancer	0.000306	0.000589	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HRAS—bile duct cancer	0.000301	0.00058	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HRAS—bile duct cancer	0.000301	0.00058	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SMAD4—bile duct cancer	0.0003	0.000578	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NRAS—bile duct cancer	0.000298	0.000573	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—EGFR—bile duct cancer	0.000297	0.000572	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KRAS—bile duct cancer	0.000292	0.000563	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—IL6—bile duct cancer	0.000288	0.000555	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—IL6—bile duct cancer	0.000288	0.000555	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HRAS—bile duct cancer	0.000287	0.000553	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KRAS—bile duct cancer	0.000281	0.000541	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—TGFB1—bile duct cancer	0.000277	0.000532	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—IL6—bile duct cancer	0.000275	0.000529	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EGFR—bile duct cancer	0.000271	0.000522	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—HRAS—bile duct cancer	0.000265	0.00051	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTGS2—bile duct cancer	0.000261	0.000503	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ERBB2—bile duct cancer	0.00026	0.000501	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KRAS—bile duct cancer	0.000256	0.000493	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—IL6—bile duct cancer	0.000254	0.000489	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—HRAS—bile duct cancer	0.000248	0.000478	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NRAS—bile duct cancer	0.000243	0.000467	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ERBB2—bile duct cancer	0.00024	0.000462	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HRAS—bile duct cancer	0.000239	0.000459	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—IL6—bile duct cancer	0.000238	0.000458	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTGS2—bile duct cancer	0.000235	0.000452	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TGFB1—bile duct cancer	0.000225	0.000434	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EGFR—bile duct cancer	0.000221	0.000426	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—HRAS—bile duct cancer	0.000218	0.000419	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KRAS—bile duct cancer	0.000209	0.000402	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—IL6—bile duct cancer	0.000208	0.000401	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NRAS—bile duct cancer	0.000198	0.000381	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NRAS—bile duct cancer	0.000183	0.000352	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGFR—bile duct cancer	0.00018	0.000347	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HRAS—bile duct cancer	0.000177	0.000342	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KRAS—bile duct cancer	0.00017	0.000328	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—IL6—bile duct cancer	0.00017	0.000327	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TGFB1—bile duct cancer	0.00017	0.000327	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ERBB2—bile duct cancer	0.000168	0.000324	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGFR—bile duct cancer	0.000166	0.00032	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KRAS—bile duct cancer	0.000157	0.000303	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HRAS—bile duct cancer	0.000145	0.000279	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP9—bile duct cancer	0.000144	0.000278	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL6—bile duct cancer	0.000139	0.000267	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HRAS—bile duct cancer	0.000134	0.000257	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NRAS—bile duct cancer	0.000128	0.000246	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IL6—bile duct cancer	0.000128	0.000246	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TGFB1—bile duct cancer	0.000119	0.000229	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGFR—bile duct cancer	0.000117	0.000224	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KRAS—bile duct cancer	0.00011	0.000212	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—bile duct cancer	9.78e-05	0.000188	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HRAS—bile duct cancer	9.36e-05	0.00018	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL6—bile duct cancer	8.96e-05	0.000172	CbGpPWpGaD
